Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt

被引：2

作者：

Bassiony, M. M. ^{[1
]}

Yousef, A. ^{[1
]}

Youssef, U. ^{[1
]}

El-Deen, Salah G. M. ^{[1
]}

Abdelghani, M. ^{[1
]}

Al-Gohari, H. ^{[1
]}

Fouad, E. ^{[1
]}

El-Shafaey, M. M. ^{[2
]}

机构：

[1] Zagazig Univ, Fac Med, Dept Psychiat, Zagazig, Egypt

[2] Zagazig Univ, Fac Med, Dept Internal Med, Zagazig, Egypt

来源：

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE | 2015年 / 50卷 / 02期

关键词：

Hepatitis C virus; depression; anxiety; interferon; ribavirin; Egypt; INTERFERON-ALPHA; PSYCHIATRIC-SYMPTOMS; RIBAVIRIN THERAPY; HOSPITAL ANXIETY; RISK-FACTORS; VIRUS; HEALTH; PEGINTERFERON; PREVALENCE; INFECTION;

D O I：

10.1177/0091217415605029

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Objectives The aim of the study was to estimate the prevalence and associated correlates of major depressive disorder and generalized anxiety disorder in hepatitis C virus patients before and after treatment and to investigate the relationship between major depressive disorder and generalized anxiety disorder and treatment response. Methods A total of 116 consecutive hepatitis C virus patients from hepatitis C virus treatment center in Zagazig city, Egypt, were included in the study and divided into treated group (N=58) and untreated group (N=58). All hepatitis C virus patients were screened for major depressive disorder and generalized anxiety disorder using hospital anxiety and depression scale, and those who screened positive were interviewed to confirm the diagnosis of major depressive disorder and generalized anxiety disorder using DSM-IV-TR diagnostic criteria. These measures were done at baseline and after 12 weeks of treatment or observation. Results At baseline, 3.5% and 12.1% of hepatitis C virus patients (treated group) had major depressive disorder and generalized anxiety disorder, respectively. After 12 weeks of treatment 37.9% of hepatitis C virus patients (treated group) had major depressive disorder and 46.6% had generalized anxiety disorder. There was a significant statistical difference between hospital anxiety and depression scale scores for depression (3.32.3 vs. 6.4 +/- 3.2, t=9.6, p=0.001) and for anxiety (4.6 +/- 2.4 vs. 7.3 +/- 3.0, t=10.2, p=0.001) before and after treatment. There was also significant statistical difference between treated group and untreated group regarding hospital anxiety and depression scale scores after treatment and observation (depression, treated group 6.4 +/- 3.2 vs. untreated group 4.0 +/- 2.4, t=3.7, p=0.001; anxiety, treated group 7.3 +/- 3.0 vs. untreated group 4.5 +/- 2.3, t=4.4, p=0.001). There was no association between major depressive disorder and generalized anxiety disorder and treatment response. Conclusions Major depressive disorder and generalized anxiety disorder are common in hepatitis C virus patients after treatment with interferon and ribavirin and were not related to treatment response.

引用

页码：147 / 162

页数：16

共 50 条

[21] Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale [J].

Sheehan, David V. ;

Harnett-Sheehan, Kathy ;

Spann, Melissa E. ;

Thompson, Harry F. ;

Prakash, Apurva .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (02) :75-83

[22] Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms [J].

Olivares, Jose M. ;

Alvarez, Enrique ;

Carrasco, Jose L. ;

Perez Paramo, Maria ;

Lopez-Gomez, Vanessa .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (05) :265-271

[23] Evaluation of depression and anxiety control in greek patients with major depressive disorder with/without generalized anxiety disorder and cardiovascular disease-pronoi study [J].

Papanastasiou, P. ;

Gourzis, P. ;

Nimatoudis, I. ;

Ginis, A. .

EUROPEAN PSYCHIATRY, 2021, 64 :S90-S90

[24] The Underlying Role of Negative Affect in the Association between PTSD, Major Depressive Disorder, and Generalized Anxiety Disorder [J].

Byllesby, Brianna M. ;

Charak, Ruby ;

Durham, Tory A. ;

Wang, Xin ;

Elhai, Jon D. .

JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 2016, 38 (04) :655-665

[25] Automaticity in anxiety disorders and major depressive disorder [J].

Teachman, Bethany A. ;

Joormann, Jutta ;

Steinman, Shari A. ;

Gotlib, Ian H. .

CLINICAL PSYCHOLOGY REVIEW, 2012, 32 (06) :575-603

[26] Symptoms of social anxiety disorder and major depressive disorder: A network perspective [J].

Langer, Julia K. ;

Tonge, Natasha A. ;

Piccirillo, Marilyn ;

Rodebaugh, Thomas L. ;

Thompson, Renee J. ;

Gotlib, Ian H. .

JOURNAL OF AFFECTIVE DISORDERS, 2019, 243 :531-538

[27] PSYCHIATRIC COMORBIDITY DOES NOT ONLY DEPEND ON DIAGNOSTIC THRESHOLDS: AN ILLUSTRATION WITH MAJOR DEPRESSIVE DISORDER AND GENERALIZED ANXIETY DISORDER [J].

van Loo, Hanna M. ;

Schoevers, Robert A. ;

Kendler, Kenneth S. ;

de Jonge, Peter ;

Romeijn, Jan-Willem .

DEPRESSION AND ANXIETY, 2016, 33 (02) :143-152

[28] The "Brightening" Effect: Reactions to Positive Events in the Daily Lives of Individuals With Major Depressive Disorder and Generalized Anxiety Disorder [J].

Khazanov, Gabriela Kattan ;

Ruscio, Ayelet Meron ;

Swendsen, Joel .

BEHAVIOR THERAPY, 2019, 50 (02) :270-284

[29] Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample [J].

Stein, MB ;

Heimberg, RG .

JOURNAL OF AFFECTIVE DISORDERS, 2004, 79 (1-3) :161-166

[30] Race and Ethnic Group Differences in Comorbid Major Depressive Disorder, Generalized Anxiety Disorder, and Chronic Medical Conditions [J].

Daphne C. Watkins ;

Shervin Assari ;

Vicki Johnson-Lawrence .

Journal of Racial and Ethnic Health Disparities, 2015, 2 :385-394

← 1 2 3 4 5 →